Orin Levine - Publications

Affiliations: 
Johns Hopkins University, Baltimore, MD 
Area:
Public Health, Epidemiology

62 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Mackenzie GA, Hill PC, Jeffries DJ, Ndiaye M, Sahito SM, Hossain I, Uchendu U, Ameh D, Adeyemi O, Pathirana J, Olatunji Y, Abatan B, Muhammad BS, Ahameefula E, ... ... Levine OS, et al. Impact of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease and pneumonia in The Gambia: 10 years of population-based surveillance. The Lancet. Infectious Diseases. PMID 34280357 DOI: 10.1016/S1473-3099(20)30880-X  0.316
2021 Mackenzie GA, Hill PC, Jeffries DJ, Ndiaye M, Sahito SM, Hossain I, Uchendu U, Ameh D, Adeyemi O, Pathirana J, Olatunji Y, Abatan B, Muhammad BS, Ahameefula E, ... ... Levine OS, et al. Impact of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease and pneumonia in The Gambia: 10 years of population-based surveillance. The Lancet. Infectious Diseases. PMID 34280357 DOI: 10.1016/S1473-3099(20)30880-X  0.316
2019 Hammitt LL, Etyang AO, Morpeth SC, Ojal J, Mutuku A, Mturi N, Moisi JC, Adetifa IM, Karani A, Akech DO, Otiende M, Bwanaali T, Wafula J, Mataza C, Mumbo E, ... ... Levine OS, et al. Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study. Lancet (London, England). PMID 31000194 DOI: 10.1016/S0140-6736(18)33005-8  0.639
2019 Silaba M, Ooko M, Bottomley C, Sande J, Benamore R, Park K, Ignas J, Maitland K, Mturi N, Makumi A, Otiende M, Kagwanja S, Safari S, Ochola V, Bwanaali T, ... ... Levine OS, et al. Effect of 10-valent pneumococcal conjugate vaccine on the incidence of radiologically-confirmed pneumonia and clinically-defined pneumonia in Kenyan children: an interrupted time-series analysis. The Lancet. Global Health. 7: e337-e346. PMID 30784634 DOI: 10.1016/S2214-109X(18)30491-1  0.372
2017 Mackenzie GA, Hill PC, Sahito SM, Jeffries DJ, Hossain I, Bottomley C, Uchendu U, Ameh D, Ndiaye M, Osuorah CD, Adeyemi O, Pathirana J, Olatunji Y, Abatan B, Ahameefula E, ... ... Levine OS, et al. Impact of the introduction of pneumococcal conjugate vaccination on pneumonia in The Gambia: population-based surveillance and case-control studies. The Lancet. Infectious Diseases. PMID 28601421 DOI: 10.1016/S1473-3099(17)30321-3  0.322
2017 Gibson DG, Ochieng B, Kagucia EW, Were J, Hayford K, Moulton LH, Levine OS, Odhiambo F, O'Brien KL, Feikin DR. Mobile phone-delivered reminders and incentives to improve childhood immunisation coverage and timeliness in Kenya (M-SIMU): a cluster randomised controlled trial. The Lancet. Global Health. 5: e428-e438. PMID 28288747 DOI: 10.1016/S2214-109X(17)30072-4  0.6
2016 Mackenzie GA, Hill PC, Jeffries DJ, Hossain I, Uchendu U, Ameh D, Ndiaye M, Adeyemi O, Pathirana J, Olatunji Y, Abatan B, Muhammad BS, Fombah AE, Saha D, Plumb I, ... ... Levine OS, et al. Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance study. The Lancet. Infectious Diseases. PMID 26897105 DOI: 10.1016/S1473-3099(16)00054-2  0.324
2014 Vasudevan L, Labrique AB, Mehra S, Wu L, Levine O, Feikin D, Klemm R, Christian P, West KP. Maternal determinants of timely vaccination coverage among infants in rural Bangladesh. Vaccine. 32: 5514-9. PMID 25132336 DOI: 10.1016/J.Vaccine.2014.06.092  0.377
2013 Hayford KT, Shomik MS, Al-Emran HM, Moss WJ, Bishai D, Levine OS. Measles vaccination coverage estimates from surveys, clinic records, and immune markers in oral fluid and blood: a population-based cross-sectional study. Bmc Public Health. 13: 1211. PMID 24359402 DOI: 10.1186/1471-2458-13-1211  0.664
2013 Feikin DR, Kagucia EW, Loo JD, Link-Gelles R, Puhan MA, Cherian T, Levine OS, Whitney CG, O'Brien KL, Moore MR. Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites. Plos Medicine. 10: e1001517. PMID 24086113 DOI: 10.1371/journal.pmed.1001517  0.316
2013 Hayford KT, Al-Emran HM, Moss WJ, Shomik MS, Bishai D, Levine OS. Validation of an anti-measles virus-specific IgG assay with oral fluid samples for immunization surveillance in Bangladesh. Journal of Virological Methods. 193: 512-8. PMID 23872267 DOI: 10.1016/J.Jviromet.2013.07.014  0.602
2012 Shearer JC, Walker DG, Risko N, Levine OS. The impact of new vaccine introduction on the coverage of existing vaccines: a cross-national, multivariable analysis. Vaccine. 30: 7582-7. PMID 23099327 DOI: 10.1016/j.vaccine.2012.10.036  0.314
2012 Mermond S, Zurawski V, D'Ortenzio E, Driscoll AJ, DeLuca AN, Deloria-Knoll M, Moïsi JC, Murdoch DR, Missotte I, Besson-Leaud L, Chevalier C, Debarnot V, Feray F, Noireterre S, Duparc B, ... ... Levine OS, et al. Lower respiratory infections among hospitalized children in New Caledonia: a pilot study for the Pneumonia Etiology Research for Child Health project. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 54: S180-9. PMID 22403234 DOI: 10.1093/Cid/Cir1070  0.6
2012 Gilchrist SA, Nanni A, Levine O. Benefits and effectiveness of administering pneumococcal polysaccharide vaccine with seasonal influenza vaccine: an approach for policymakers. American Journal of Public Health. 102: 596-605. PMID 22397339 DOI: 10.2105/Ajph.2011.300512  0.425
2012 Mackenzie GA, Plumb ID, Sambou S, Saha D, Uchendu U, Akinsola B, Ikumapayi UN, Baldeh I, Usuf E, Touray K, Jasseh M, Howie SR, Wattiaux A, Lee E, Knoll MD, ... Levine OS, et al. Monitoring the introduction of pneumococcal conjugate vaccines into West Africa: design and implementation of a population-based surveillance system. Plos Medicine. 9: e1001161. PMID 22272192 DOI: 10.1371/Journal.Pmed.1001161  0.337
2011 Nakamura MM, Tasslimi A, Lieu TA, Levine O, Knoll MD, Russell LB, Sinha A. Cost effectiveness of child pneumococcal conjugate vaccination in middle-income countries. International Health. 3: 270-81. PMID 24038500 DOI: 10.1016/J.Inhe.2011.08.004  0.437
2011 Tasslimi A, Nakamura MM, Levine O, Knoll MD, Russell LB, Sinha A. Cost effectiveness of child pneumococcal conjugate vaccination in GAVI-eligible countries. International Health. 3: 259-69. PMID 24038499 DOI: 10.1016/J.Inhe.2011.08.003  0.426
2011 Levine OS, Bloom DE, Cherian T, de Quadros C, Sow S, Wecker J, Duclos P, Greenwood B. The future of immunisation policy, implementation, and financing. Lancet (London, England). 378: 439-48. PMID 21664676 DOI: 10.1016/S0140-6736(11)60406-6  0.325
2011 Stack ML, Ozawa S, Bishai DM, Mirelman A, Tam Y, Niessen L, Walker DG, Levine OS. Estimated economic benefits during the 'decade of vaccines' include treatment savings, gains in labor productivity. Health Affairs (Project Hope). 30: 1021-8. PMID 21653952 DOI: 10.1377/Hlthaff.2011.0382  0.301
2011 Ozawa S, Stack ML, Bishai DM, Mirelman A, Friberg IK, Niessen L, Walker DG, Levine OS. During the 'decade of vaccines,' the lives of 6.4 million children valued at $231 billion could be saved. Health Affairs (Project Hope). 30: 1010-20. PMID 21653951 DOI: 10.1377/Hlthaff.2011.0381  0.322
2011 Dagan R, Bhutta ZA, de Quadros CA, Garau J, Klugman KP, Khuri-Bulos N, Levine O, Saha SK, Sow S, Were F, Yang Y. The remaining challenge of pneumonia: the leading killer of children. The Pediatric Infectious Disease Journal. 30: 1-2. PMID 21076365 DOI: 10.1097/Inf.0B013E3182005389  0.328
2010 Dagan R, de Quadros CA, Garau J, Klugman KP, Khuri-Bulos N, Levine O, Sow S, Yang Y. Marking November 12, 2010 - World Pneumonia Day: where are we, where are vaccines? Human Vaccines. 6: 922-5. PMID 21045539 DOI: 10.4161/Hv.6.11.13599  0.352
2010 Fitzwater SP, Watt JP, Levine OS, Santosham M. Haemophilus influenzae type b conjugate vaccines: considerations for vaccination schedules and implications for developing countries. Human Vaccines. 6: 810-8. PMID 20980793 DOI: 10.4161/Hv.6.10.13017  0.327
2010 Johnson HL, Deloria-Knoll M, Levine OS, Stoszek SK, Freimanis Hance L, Reithinger R, Muenz LR, O'Brien KL. Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. Plos Medicine. 7. PMID 20957191 DOI: 10.1371/Journal.Pmed.1000348  0.352
2010 Ramakrishnan M, Moïsi JC, Etame MM, Klugman KP, Feris JM, Levine OS. Invasive infections and sickle-cell disease - Authors' reply The Lancet Infectious Diseases. 10: 593-594. PMID 20797638 DOI: 10.1016/S1473-3099(10)70181-X  0.609
2010 Moïsi JC, Kabuka J, Mitingi D, Levine OS, Scott JA. Spatial and socio-demographic predictors of time-to-immunization in a rural area in Kenya: Is equity attainable? Vaccine. 28: 5725-30. PMID 20600489 DOI: 10.1016/J.Vaccine.2010.06.011  0.329
2010 Ramakrishnan M, Moïsi JC, Klugman KP, Iglesias JM, Grant LR, Mpoudi-Etame M, Levine OS. Increased risk of invasive bacterial infections in African people with sickle-cell disease: a systematic review and meta-analysis. The Lancet. Infectious Diseases. 10: 329-37. PMID 20417415 DOI: 10.1016/S1473-3099(10)70055-4  0.618
2010 Levine OS, Knoll MD, Jones A, Walker DG, Risko N, Gilani Z. Global status of Haemophilus influenzae type b and pneumococcal conjugate vaccines: evidence, policies, and introductions. Current Opinion in Infectious Diseases. 23: 236-41. PMID 20407316 DOI: 10.1097/Qco.0B013E328338C135  0.347
2009 Rehm SJ, Farley MM, File TM, Hall WJ, Hopkins R, Levine OS, Nichol KL, Nuorti P, Zimmerman RK, Schaffner W. Higher pneumococcal disease vaccination rates needed to protect more at-risk US adults. Postgraduate Medicine. 121: 101-5. PMID 19940420 DOI: 10.3810/pgm.2009.11.2069  0.335
2009 Ramakrishnan M, Ulland AJ, Steinhardt LC, Moïsi JC, Were F, Levine OS. Sequelae due to bacterial meningitis among African children: a systematic literature review. Bmc Medicine. 7: 47. PMID 19751516 DOI: 10.1186/1741-7015-7-47  0.6
2009 Watt JP, Wolfson LJ, O'Brien KL, Henkle E, Deloria-Knoll M, McCall N, Lee E, Levine OS, Hajjeh R, Mulholland K, Cherian T. Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates. Lancet (London, England). 374: 903-11. PMID 19748399 DOI: 10.1016/S0140-6736(09)61203-4  0.343
2009 O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, Lee E, Mulholland K, Levine OS, Cherian T. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet (London, England). 374: 893-902. PMID 19748398 DOI: 10.1016/S0140-6736(09)61204-6  0.313
2009 Knoll MD, Moïsi JC, Muhib FB, Wonodi CB, Lee EH, Grant L, Gilani Z, Anude CJ, O'Brien KL, Cherian T, Levine OS. Standardizing surveillance of pneumococcal disease. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 48: S37-48. PMID 19191618 DOI: 10.1086/596480  0.636
2008 Madhi SA, Levine OS, Hajjeh R, Mansoor OD, Cherian T. Vaccines to prevent pneumonia and improve child survival. Bulletin of the World Health Organization. 86: 365-72. PMID 18545739 DOI: 10.2471/BLT.07.044503  0.346
2007 Levine O, Cherian T. Do Indian children need pneumococcal vaccination? (Reply) [2] Indian Pediatrics. 44: 791-792. PMID 17998585  0.333
2007 Levine OS, Cherian T. Pneumococcal vaccination for Indian children. Indian Pediatrics. 44: 491-6. PMID 17684301  0.329
2007 Sinha A, Levine O, Knoll MD, Muhib F, Lieu TA. Cost-effectiveness of pneumococcal conjugate vaccination in the prevention of child mortality: an international economic analysis. Lancet (London, England). 369: 389-96. PMID 17276779 DOI: 10.1016/S0140-6736(07)60195-0  0.402
2006 Dentinger CM, Hennessy TW, Bulkow LR, Reasonover AL, Romero-Steiner S, Holder PF, de Leon PG, Carlone GM, Parks DJ, Parkinson AJ, Singleton RJ, Levine OS, Butler JC. Immunogenicity and reactogenicity to Haemophilus influenzae type B (Hib) conjugate vaccine among rural Alaska adults. Human Vaccines. 2: 24-8. PMID 17012896  0.323
2006 Moïsi JC, Levine OS, Watt JP. Sensitivity of surveillance for Haemophilus influenzae Type b meningitis. The Pediatric Infectious Disease Journal. 25: 960. PMID 17006304 DOI: 10.1097/01.Inf.0000235748.52411.A9  0.566
2006 Garcia S, Levine OS, Cherian T, Gabastou JM, Andrus J. Pneumococcal disease and vaccination in the Americas: an agenda for accelerated vaccine introduction. Revista Panamericana De Salud PúBlica = Pan American Journal of Public Health. 19: 340-8. PMID 16805976 DOI: 10.1590/S1020-49892006000500007  0.352
2006 Baggett HC, Hennessy TW, Bulkow L, Romero-Steiner S, Hurlburt D, Holder P, Parkinson AJ, Singleton RJ, Levine O, Carlone GM, Butler JC. Immunologic response to Haemophilus influenzae type b (Hib) conjugate vaccine and risk factors for carriage among Hib carriers and noncarriers in Southwestern Alaska. Clinical and Vaccine Immunology : Cvi. 13: 620-6. PMID 16760318 DOI: 10.1128/Cvi.00077-06  0.427
2005 Cutts FT, Zaman SM, Enwere G, Jaffar S, Levine OS, Okoko JB, Oluwalana C, Vaughan A, Obaro SK, Leach A, McAdam KP, Biney E, Saaka M, Onwuchekwa U, Yallop F, et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet (London, England). 365: 1139-46. PMID 15794968 DOI: 10.1016/S0140-6736(05)71876-6  0.355
2004 Martin M, Casellas JM, Madhi SA, Urquhart TJ, Delport SD, Ferrero F, Chamany S, Dayan GH, Rose CE, Levine OS, Klugman KP, Feikin DR. Impact of haemophilus influenzae type b conjugate vaccine in South Africa and Argentina. The Pediatric Infectious Disease Journal. 23: 842-7. PMID 15361724 DOI: 10.1097/01.Inf.0000137575.82874.0C  0.334
2004 Feikin DR, Nelson CB, Watt JP, Mohsni E, Wenger JD, Levine OS. Rapid assessment tool for Haemophilus influenzae type b disease in developing countries. Emerging Infectious Diseases. 10: 1270-6. PMID 15324548 DOI: 10.3201/eid1007.030737  0.348
2003 Watt JP, Levine OS, Santosham M. Global reduction of Hib disease: what are the next steps? Proceedings of the meeting Scottsdale, Arizona, September 22-25, 2002. The Journal of Pediatrics. 143: S163-87. PMID 14657805 DOI: 10.1067/S0022-3476(03)00576-6  0.353
2002 Lucher LA, Reeves M, Hennessy T, Levine OS, Popovic T, Rosenstein N, Parkinson AJ. Reemergence, in southwestern Alaska, of invasive Haemophilus influenzae type b disease due to strains indistinguishable from those isolated from vaccinated children. The Journal of Infectious Diseases. 186: 958-65. PMID 12232836 DOI: 10.1086/342595  0.302
2000 Gomez E, Peguero M, Sanchez J, Castellanos PL, Feris J, Peña C, Brudzinski-LaClaire L, Levine OS. Population-based surveillance for bacterial meningitis in the Dominican Republic: implications for control by vaccination. Epidemiology and Infection. 125: 549-54. PMID 11218205 DOI: 10.1017/S0950268800004830  0.365
2000 Millar EV, O'Brien KL, Levine OS, Kvamme S, Reid R, Santosham M. Toward elimination of Haemophilus influenzae type B carriage and disease among high-risk American Indian children. American Journal of Public Health. 90: 1550-4. PMID 11029987 DOI: 10.2105/Ajph.90.10.1550  0.384
2000 Singleton R, Bulkow LR, Levine OS, Butler JC, Hennessy TW, Parkinson A. Experience with the prevention of invasive Haemophilus influenzae type b disease by vaccination in Alaska: The impact of persistent oropharyngeal carriage Journal of Pediatrics. 137: 313-320. PMID 10969253 DOI: 10.1067/mpd.2000.107843  0.375
1999 Levine OS, Lagos R, Muñoz A, Villaroel J, Alvarez AM, Abrego P, Levine MM. Defining the burden of pneumonia in children preventable by vaccination against Haemophilus influenzae type b Pediatric Infectious Disease Journal. 18: 1060-1064. PMID 10608624  0.362
1999 Fiore AE, Levine OS, Elliott JA, Facklam RR, Butler JC. Effectiveness of pneumococcal polysaccharide vaccine for preschool-age children with chronic disease Emerging Infectious Diseases. 5: 828-831. PMID 10603221  0.347
1999 Mulholland K, Levine O, Nohynek H, Greenwood BM. Evaluation of vaccines for the prevention of pneumonia in children in developing countries Epidemiologic Reviews. 21: 43-55. PMID 10520472 DOI: 10.1093/Oxfordjournals.Epirev.A017987  0.442
1999 Galil K, Singleton R, Levine OS, Fitzgerald MA, Bulkow L, Getty M, Perkins BA, Parkinson A. Reemergence of invasive Haemophilus influenzae type b disease in a well-vaccinated population in remote Alaska. The Journal of Infectious Diseases. 179: 101-6. PMID 9841828 DOI: 10.1086/314569  0.362
1998 Levine OS, Schwartz B. The rationale for population-based surveillance for Haemophilus influenzae type b meningitis Pediatric Infectious Disease Journal. 17. PMID 9781762 DOI: 10.1097/00006454-199809001-00024  0.366
1998 Lagos R, Levine OS, Avendaño A, Horwitz I, Levine MM. The introduction of routine Haemophilus influenzae type b conjugate vaccine in Chile: A framework for evaluating new vaccines in newly industrializing countries Pediatric Infectious Disease Journal. 17. PMID 9781748 DOI: 10.1097/00006454-199809001-00010  0.339
1998 Levine OS, Schwartz B, Pierce N, Kane M. Development, evaluation and implementation of Haemophilus influenzae type b vaccines for young children in developing countries: current status and priority actions. The Pediatric Infectious Disease Journal. 17: S95-113. PMID 9781741 DOI: 10.1097/00006454-199809001-00003  0.308
1998 Gómez E, Moore A, Sánchez J, Kool J, Castellanos PL, Feris JM, Kolczak M, Levine OS. The epidemiology of Haemophilus influenzae type b carriage among infants and young children in Santo Domingo, Dominican Republic Pediatric Infectious Disease Journal. 17: 782-786. PMID 9779761 DOI: 10.1097/00006454-199809000-00006  0.333
1998 Levine MM, Lagos R, Levine OS, Heitmann I, Enriquez N, Eugenia M, Alvarez AM, Mayorga C, Reyes A. Epidemiology of invasive pneumococcal infections in infants and young children in Metropolitan Santiago, Chile, a newly industrializing country Pediatric Infectious Disease Journal. 17: 287-293. PMID 9576382 DOI: 10.1097/00006454-199804000-00005  0.327
1998 Rosenstein N, Levine O, Taylor JP, Evans D, Plikaytis BD, Wenger JD, Perkins BA. Efficacy of meningococcal vaccine and barriers to vaccination. Jama. 279: 435-9. PMID 9466635 DOI: 10.1001/Jama.279.6.435  0.396
1997 Levine MM, Levine OS. Influence of disease burden, public perception, and other factors on new vaccine development, implementation, and continued use Lancet. 350: 1386-1392. PMID 9365466 DOI: 10.1016/S0140-6736(97)03253-4  0.317
1997 Galil K, Singleton R, Levine O, Fitzgerald M, Ajello Q, Bulkow L, Parkinson A. High prevalence of Haemophilus influenzae type b (Hib) carriage among alaska natives despite widespread use of hib conjugate vaccine Clinical Infectious Diseases. 25: 433.  0.369
1996 Lagos R, Horwitz I, Toro J, Martin OS, Abrego P, Bustamante C, Wasserman SS, Levine OS, Levine MM. Large scale, postlicensure, selective vaccination of Chilean infants with PRP-T conjugate vaccine: Practicality and effectiveness in preventing invasive Haemophilus influenzae type b infections Pediatric Infectious Disease Journal. 15: 216-222. PMID 8852909 DOI: 10.1097/00006454-199603000-00008  0.33
Show low-probability matches.